Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Gabriella CirmenaLorenzo FerrandoFrancesco RaveraAnna GarutiMartina DameriMaurizio GalloValentina BarberoFabio FerrandoLucia Del MastroAlessandro GarlaschiDaniele FriedmanPiero FregattiAlberto BallestreroFrancesco RaveraPublished in: JCO precision oncology (2022)
cfDI index measured after NACT completion shows great potential in the assessment of pCR in patients with BC. The evaluation of its use in combination with MRI is strongly warranted in prospective studies.